Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
19
Number of overlapping holdings
9.7%
% of IBBQ's 196 holdings also in IBRN
46.3%
% of IBRN's 55 holdings also in IBBQ
Overlap by Weight
Sector Drift (IBBQ minus IBRN)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBBQ |
Weight in IBRN |
Overlap | |
|---|---|---|---|---|
 |
BIOGEN IDEC INC | 2.3% | 3.0% | 2.3% |
 |
ARGENX SE ADR | 2.1% | 4.5% | 2.1% |
|
NEUROCRINE BIOSCIENCES INC | 1.4% | 4.3% | 1.4% |
|
SAREPTA THERAPEUTICS INC | 1.3% | 3.9% | 1.3% |
|
INTRA-CELLULAR THERAPIES INC | 0.9% | 4.6% | 0.9% |
Position Highlights (Non-Overlapping Exposures)
IBBQ Overweight Relative to IBRN
|
GILEAD SCIENCES INC | 10.2% |
|
VERTEX PHARMACEUTICALS INC | 8.2% |
|
AMGEN INC | 7.1% |
|
REGENERON PHARMACEUTICALS | 5.4% |
 |
ASTRAZENECA PLC-SPONS ADR | 4.1% |
|
ALNYLAM PHARMACEUTICALS INC | 3.4% |
|
ILLUMINA INC | 2.4% |
|
UNITED THERAPEUTICS CORP | 1.7% |
|
MODERNA, INC. | 1.7% |
|
VIATRIS, INC. | 1.6% |
IBBQ Underweight Relative to IBRN
|
PTC THERAPEUTICS INC | -5.6% |
|
SCHOLAR ROCK HOLDING CORP. | -5.1% |
|
CATALYST PHARMACEUTICAL PART | -4.4% |
 |
ALKERMES PLC | -4.1% |
|
ACADIA PHARMACEUTICALS INC | -4.1% |
 |
SK BIOPHARMACEUTICALS CO., LTD. | -3.8% |
|
INTRA-CELLULAR THERAPIES INC | -3.6% |
|
SUPERNUS PHARMACEUTICALS INC | -3.6% |
|
INTEGRA LIFESCIENCES HOLDING | -3.1% |
|
EDGEWISE THERAPEUTICS, INC. | -2.9% |